Public Health and Safety Consequences of Liberalizing Drug Laws

Insights from Cannabis Legalization

by Steven Davenport

Download eBook for Free

FormatFile SizeNotes
PDF file 5.3 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Cannabis has been legalized for non-medical purposes in Canada, Uruguay, eleven U.S. states and Washington DC, with others likely to follow. The world's first large corporate cannabis producers and retailers are operating in Canada and the United States — with the potential for continued expansions in scale and efficiency in the case of national legalization in the United States. This accelerated rate of policy change prompts novel topics of cannabis policy research, including evaluating past policy changes and identifying feasible policy responses for contemporary or anticipated issues.

This dissertation includes four papers. Three concern issues related to cannabis, with the last investigating a related issue (intoxicated driving) manifesting in alcohol policy. The first chapter identifies U.S. national-level patterns of cannabis acquisition and use and from 2002 to 2013, roughly the decade of policy liberalization that preceded the first non-medical cannabis regimes. The second chapter investigates a surprising fifteen-year trend in self-report of cannabis use disorder symptoms among daily/near-daily cannabis users, who disproportionately bear many of the consequences of cannabis use. The third chapter analyzes Washington State's recreational cannabis traceability dataset (July 2014-October 2017), documenting emerging trends, e.g. declining prices, cannabinoid profiles, and product forms. The final chapter evaluates an intervention relating to reducing alcohol-involved crashes, some lessons of which can be carried over to analogous questions with cannabis-involved crashes. That study evaluated Uruguay's zero blood-alcohol-concentration (BAC) law, exploiting a novel synthetic controls method to estimate reductions in severe and fatal injury crashes, using Chile as a control.

A central theme is the potential for a rising public health risk among adult cannabis users, and which may or may not meet clinical diagnoses for cannabis use disorder. There remain puzzles to solve. As the political-economic landscape regarding cannabis continues to evolve, public health-oriented policymakers would be wise to invest time and research in monitoring use trends in detail, and refining definitions and measurements of problematic cannabis use. It is the hope of this dissertation to support that line of inquiry.

Table of Contents

  • Chapter One

    Evolution of the United States Marijuana Market in the Decade of Liberalization Before Full Legalization

  • Chapter Two

    Falling rates of marijuana dependence among heavy users

  • Chapter Three

    Price and Product Variation in Washington's Recreational Cannabis Market

  • Chapter Four

    Associations Between a Zero Tolerance BAC Law and Traffic Crashes and Fatalities: Insights from a Novel Synthetic Control Method

Research conducted by

This document was submitted as a dissertation in June 2020 in partial fulfillment of the requirements of the doctoral degree in public policy analysis at the Pardee RAND Graduate School. The faculty committee that supervised and approved the dissertation consisted of Gery Ryan (Chair), Jonathan Caulkins, and Beau Kilmer.

This publication is part of the RAND Corporation Dissertation series. Pardee RAND dissertations are produced by graduate fellows of the Pardee RAND Graduate School, the world's leading producer of Ph.D.'s in policy analysis. The dissertations are supervised, reviewed, and approved by a Pardee RAND faculty committee overseeing each dissertation.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.